论文部分内容阅读
目的:探究米非司酮治疗围绝经期功能性子宫出血的临床效果。方法:对我院2014年7月到2015年12月间接收的64例围绝经期功能性子宫出血患者进行治疗,按照随机序号法将患者分为对照组和观察组,对照组采用黄体酮治疗,观察组采用米非司酮治疗,观察两组效果并进行比较。结果:观察组治疗有效率高于对照组,两组比较差异明显,P<0.05,差异具有统计学意义。对患者的临床情况进行观察发现,观察组不良反应发生率少于对照组,组间比较均存在明显差异,P<0.05,差异具有统计学意义。结论:米非司酮治疗围绝经期功能性子宫出血的临床效果良好,同时不良反应较少,因而值得临床借鉴使用。
Objective: To investigate the clinical efficacy of mifepristone in treating peri-menopausal dysfunctional uterine bleeding. Methods: Sixty-four patients with functional uterine bleeding during the period from July 2014 to December 2015 in our hospital were treated. According to the random number method, the patients were divided into the control group and the observation group. The control group received progesterone treatment , The observation group with mifepristone treatment, the two groups were observed and compared. Results: The effective rate of observation group was higher than that of control group, with significant difference between the two groups (P <0.05). The difference was statistically significant. The clinical observation of patients found that the incidence of adverse reactions in the observation group less than the control group, there were significant differences between groups, P <0.05, the difference was statistically significant. Conclusion: The clinical efficacy of mifepristone in the treatment of peri-menopausal functional uterine bleeding is good, with fewer adverse reactions, which is worthy of clinical reference.